KALAVSPRME• 12 Months (Normalized)
KALA vs PRME (KALA BIO Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
KALA Performance $0.54
-99.94%
KALA BIO Inc.
Normalized Baseline0.00%
PRME Performance $3.18
-20.7%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PRME LEADS
-79.24%
PRME outperforming by 79.24%
KALAPRME
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
KALA PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | KALA Price | KALA Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.54 | -99.94% | $3.18 | -20.70% | -79.24% |
| Sep 11, 2026 | $0.57 | -99.94% | $3.13 | -21.95% | -77.99% |
| Sep 10, 2026 | $0.56 | -99.94% | $3.35 | -16.46% | -83.48% |
| Sep 09, 2026 | $0.56 | -99.94% | $3.47 | -13.47% | -86.47% |
| Sep 08, 2026 | $0.54 | -99.94% | $3.56 | -11.22% | -88.72% |
| Sep 04, 2026 | $0.51 | -99.95% | $3.70 | -7.73% | -92.22% |
| Sep 03, 2026 | $0.56 | -99.94% | $3.71 | -7.48% | -92.46% |
| Sep 02, 2026 | $0.52 | -99.95% | $3.67 | -8.48% | -91.47% |
| Sep 01, 2026 | $0.53 | -99.94% | $3.57 | -10.97% | -88.97% |
| Aug 31, 2026 | $0.67 | -99.93% | $3.59 | -10.47% | -89.46% |
| Aug 28, 2026 | $0.69 | -99.93% | $3.61 | -9.98% | -89.95% |
| Aug 27, 2026 | $0.81 | -99.92% | $3.64 | -9.23% | -90.69% |
| Aug 26, 2026 | $0.82 | -99.92% | $3.58 | -10.72% | -89.20% |
| Aug 25, 2026 | $0.82 | -99.91% | $3.71 | -7.48% | -92.43% |
| Aug 24, 2026 | $0.80 | -99.92% | $3.25 | -18.95% | -80.97% |
Page 1 of 17